The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease

By de Jong P.C.   Blankenstein M.A.   Nortier J.W.R.   Slee P.H.T.J.   van de Ven J.   van Gorp J.M.H.H.   Elbers J.R.J.   Schipper M.E.I.   Blijham G.H.   Thijssen J.H.H.   Lu Q.   Jelovac D.   Brodie A.M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 87, Iss. 2, 2003-11 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Development of Steroidal Aromatase Inhibitors

By  

Current Enzyme Inhibition, Vol. 2, Iss. 2, 2006-05 ,pp. : 189-198

Bentham Science Publishers

Access to resources Recommend Favorite

The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens

By Brodie A.H.   Jelovac D.   Long B.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 283-288

Elsevier

Access to resources Recommend Favorite

Novel oxazolidinone based compounds as inhibitors of aromatase and the use of the substrate–heme complex approach in the rationalisation of these compounds

By Ahmed S.   Adat S.   Murrells A.   Owen C.P.  

Biochemical and Biophysical Research Communications, Vol. 294, Iss. 2, 2002-06 ,pp. : 380-383

Elsevier

Access to resources Recommend Favorite

Design, synthesis, and evaluation of 4-(4^′-aminobenzyl)-2-oxazolidinones as novel inhibitors of the cytochrome P-450 enzyme aromatase

By Ahmed S.   Adat S.   Murrells A.   Owen C.P.   Amanuel Y.  

Bioorganic Chemistry, Vol. 30, Iss. 5, 2002-10 ,pp. : 315-331

Academic Press

Access to resources Recommend Favorite